Quick Takeaways
- CITADEL ADVISORS LLC filed SCHEDULE 13G/A for Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (the "Shares") (TERN).
- Disclosed ownership: 4.1%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"CITADEL ADVISORS LLC disclosed 4.1% ownership in Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (the "Shares") (TERN) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Citadel Advisors LLC | 3.9% | 3,267,779 | 0 | 3,267,779 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Advisors Holdings LP | 3.9% | 3,267,779 | 0 | 3,267,779 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel GP LLC | 3.9% | 3,267,779 | 0 | 3,267,779 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities LLC | 0.2% | 197,528 | 0 | 197,528 | /s/ Guy Miller | Guy Miller, Authorized Signatory | |
| Citadel Securities Group LP | 0.2% | 197,528 | 0 | 197,528 | /s/ Guy Miller | Guy Miller, Authorized Signatory | |
| Citadel Securities GP LLC | 0.2% | 197,528 | 0 | 197,528 | /s/ Guy Miller | Guy Miller, Authorized Signatory | |
| Kenneth Griffin | 4.1% | 3,465,307 | 0 | 3,465,307 | /s/ Seth Levy | Seth Levy, attorney-in-fact* |